Hormone fluctuations. Hot flashes and night sweats. Depression and changes in mood. Coincidental and age-related changes in health and social issues. All of these factors associated with menopause can affect a patient’s sleep quality.
Hormone fluctuations. Hot flashes and night sweats. Depression and changes in mood. Coincidental and age-related changes in health and social issues. All of these factors associated with menopause can affect a patient’s sleep quality. In fact, according to one estimate, the prevalence of insomnia rises by approximately 40% during the period of transition to menopause and after menopause. Since sleep is so crucial to well-being, what can be done to help patients suffering from menopause-related sleep disturbances?
We invited Dr Howard Kravitz to shed some light on sleep disturbances associated with menopause. Dr Kravitz is the Stanley G Harris Family Professor of Psychiatry and professor of preventive medicine at Rush University Medical Center. He has published extensively on sleep and sleep issues, particularly in mid-life and menopausal women.
Take-Home Tips:
• Don’t wait for the patient to ask you about sleep issues. Since menopause-related sleep issues are so prevalent, talk to your patient about potential symptoms and sleep quality issues.
• Know your resources. Refer patients to sleep disorder centers or psychiatrists/psychologists as necessary.
• Women may be interested in herbal/alternative medicines, but research indicates that, at best, they are not helpful and at worst, they are dangerous. Talk to your patients, find out what they have read and why they are interested in such, and negotiate a safe treatment plan.
Resources for Patients:
Menopause and Sleep, from the National Sleep FoundationSleep and Menopause, WebMD
To Sleep, Perchance To Dream: Recognizing and Addressing Menopause-Related Sleep Disruption
FDA adds boxed warning to fezolinetant for rare serious liver injury
Published: December 17th 2024 | Updated: December 17th 2024The FDA has added a boxed warning for fezolinetant (VEOZAH; Astellas), highlighting the rare occurrence of serious liver injury in patients taking the menopause treatment.
Read More
Shared genetics found between anti-Müllerian hormone and age at menopause
December 4th 2024In a recent study, an inverse relationship was discovered between anti-Müllerian hormone levels and early menopause, highlighting the need to develop interventions for fertility preservation based on genetics.
Read More
FDA adds boxed warning to fezolinetant for rare serious liver injury
Published: December 17th 2024 | Updated: December 17th 2024The FDA has added a boxed warning for fezolinetant (VEOZAH; Astellas), highlighting the rare occurrence of serious liver injury in patients taking the menopause treatment.
Read More
Shared genetics found between anti-Müllerian hormone and age at menopause
December 4th 2024In a recent study, an inverse relationship was discovered between anti-Müllerian hormone levels and early menopause, highlighting the need to develop interventions for fertility preservation based on genetics.
Read More
2 Commerce Drive
Cranbury, NJ 08512